Dr. Rader is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4881 NE Goodview Circle
Lee's Summit, MO 64064Phone+1 913-588-1227
Summary
- Dr. Ryan Rader is a Clinical Assistant Professor of Medical Oncology at the University of Kansas with a primary focus on breast cancer. He completed his Hematology/Oncology fellowship at Duke University and internal medicine residency at Cleveland Clinic. He received his medical degree from University of Missouri-Columbia School of Medicine.
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
- Cleveland Clinic FoundationResidency, Internal Medicine, 2017 - 2020
- University of Missouri-Columbia School of MedicineClass of 2017
Certifications & Licensure
- MO State Medical License 2023 - 2026
- KS State Medical License 2023 - 2025
- NC State Medical License 2020 - 2024
- OH State Medical License 2020 - 2023
- AL State Medical License 2021 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsAvailable Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases.Ryan K Rader, Carey K Anders, Nancy U Lin, Sarah L Sammons
Current Treatment Options in Oncology. 2023-06-01 - 9 citationsAddressing the Crisis in the Treatment of Osteoporosis: Better Paths Forward.William V. Stoecker, Aaron Carson, Vu H. Nguyen, Alex B Willis, Justin G. Cole
Journal of Bone and Mineral Research. 2017-05-15 - 13 citationsBiologically inspired skin lesion segmentation using a geodesic active contour technique.Reda Kasmi, Karim Mokrani, Ryan K. Rader, Justin G. Cole, William V. Stoecker
Skin Research and Technology. 2016-05-01
Press Mentions
- Patient Selection Takes Priority as Standard of Cares Shift in HR+ and HER2+ Breast CanceJuly 14th, 2024
Professional Memberships
- Missouri State Medical AssociationStudent Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: